Journal

Learn how to interpret CredibleMeds categories, distinguish medicine classifications from patient risk and document a focused prescribing review.

Verify an AI medical-device claim against the exact manufacturer, product record, intended purpose and jurisdiction rather than a marketing badge.

Map intended purpose, inputs and outputs before assessing a mixed medical-learning and clinical-reference platform, with UK and US rules kept separate.

Build a release record that connects an AI component change to affected tasks, regression evidence, approval, monitoring and rollback.

Distinguish AI retrieval, grounding, citation and engagement when assessing medical-library use, without treating draft reporting proposals as final standards.

Separate reading, retrieval, display and training rights when assessing clinical AI content agreements, using a practical rights-register example.

Separate registration, verification, licensure and meaningful activity before comparing healthcare AI adoption figures or retained use.

Model AI medical simulation using completed encounters, feedback, retries and support, with explicitly hypothetical costs rather than misleading token-only margins.

Choose review software by the decisions and records your team must preserve, rather than by an AI label or a promise of faster screening.

Write a specialist advice request that makes the decision, urgency, relevant evidence and responsibility for follow-up clear.

Use OpenPrescribing measures, denominators and trends to choose a focused prescribing review without mistaking a dashboard ranking for a clinical verdict.

Turn a Liverpool interaction warning into a documented clinical question by checking the medicines, mechanism, evidence and proposed action.